Viewing Study NCT00665457


Ignite Creation Date: 2025-12-24 @ 7:02 PM
Ignite Modification Date: 2026-05-04 @ 1:09 PM
Study NCT ID: NCT00665457
Status: TERMINATED
Last Update Posted: 2023-09-13
First Post: 2008-04-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery
Sponsor: University of Nebraska
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage II breast cancer View
None stage IIIA breast cancer View
None stage IIIB breast cancer View
None stage IIIC breast cancer View